Literature DB >> 19454454

Cervical cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

C Haie-Meder1, P Morice, M Castiglione.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19454454     DOI: 10.1093/annonc/mdp119

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2-IIB cervical cancer.

Authors:  E Chéreau; J-G Feron; M Ballester; C Coutant; C Bezu; R Rouzier; E Touboul; E Daraï
Journal:  Br J Cancer       Date:  2011-12-06       Impact factor: 7.640

2.  Prognostic Value of Neutrophil-Related Factors in Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy.

Authors:  Yan-Yang Wang; Zhou-Lan Bai; Jian-Li He; Yan Yang; Ren Zhao; Ping Hai; Hong Zhe
Journal:  Dis Markers       Date:  2016-03-20       Impact factor: 3.434

3.  Chemoradiotherapy alone vs. chemoradiotherapy and hysterectomy for locally advanced cervical cancer: A systematic review and updated meta-analysis.

Authors:  Weijia Lu; Canxiong Lu; Zhiwu Yu; Lei Gao
Journal:  Oncol Lett       Date:  2020-12-31       Impact factor: 2.967

4.  ERCC1 mRNA levels can predict the response to cisplatin-based concurrent chemoradiotherapy of locally advanced cervical squamous cell carcinoma.

Authors:  Zhou-lan Bai; Yan-yang Wang; Hong Zhe; Jian-li He; Ping Hai
Journal:  Radiat Oncol       Date:  2012-12-23       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.